Impact of Colchicine in Hospitalized Colombian Patients With COVID-19

NCT04539873 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

128

Enrollment

OTHER

Sponsor class

Stopped non-inclusion of patients in the study effectively

Conditions

Corona Virus Infection

Interventions

DRUG: Colchicine 0.5 MG
COMBINATION_PRODUCT: CONTROL GROUP

Sponsor

Fundación Universitaria de Ciencias de la Salud

Collaborators

[object Object]